AU2019350525B2 - Synthetic method for the preparation of a 3-[5-Amino-4-(3-Cyanobenzoyl)-Pyrazol compound - Google Patents

Synthetic method for the preparation of a 3-[5-Amino-4-(3-Cyanobenzoyl)-Pyrazol compound Download PDF

Info

Publication number
AU2019350525B2
AU2019350525B2 AU2019350525A AU2019350525A AU2019350525B2 AU 2019350525 B2 AU2019350525 B2 AU 2019350525B2 AU 2019350525 A AU2019350525 A AU 2019350525A AU 2019350525 A AU2019350525 A AU 2019350525A AU 2019350525 B2 AU2019350525 B2 AU 2019350525B2
Authority
AU
Australia
Prior art keywords
compound
optionally
reaction mass
reaction
filtrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019350525A
Other languages
English (en)
Other versions
AU2019350525A1 (en
Inventor
Benjamin Martin
Mark Meisenbach
Niek Johannes Ronde
Carmen RUIZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mereo Biopharma 1 Ltd
Original Assignee
Mereo Biopharma 1 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mereo Biopharma 1 Ltd filed Critical Mereo Biopharma 1 Ltd
Publication of AU2019350525A1 publication Critical patent/AU2019350525A1/en
Application granted granted Critical
Publication of AU2019350525B2 publication Critical patent/AU2019350525B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10Hydrazines
    • C07C243/22Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2019350525A 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-Amino-4-(3-Cyanobenzoyl)-Pyrazol compound Active AU2019350525B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1815695.0 2018-09-26
GBGB1815695.0A GB201815695D0 (en) 2018-09-26 2018-09-26 Synthetic method
PCT/GB2019/052718 WO2020065323A1 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound

Publications (2)

Publication Number Publication Date
AU2019350525A1 AU2019350525A1 (en) 2021-04-15
AU2019350525B2 true AU2019350525B2 (en) 2024-05-02

Family

ID=64024269

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019350525A Active AU2019350525B2 (en) 2018-09-26 2019-09-26 Synthetic method for the preparation of a 3-[5-Amino-4-(3-Cyanobenzoyl)-Pyrazol compound

Country Status (12)

Country Link
US (1) US11649213B2 (https=)
EP (1) EP3856721B1 (https=)
JP (1) JP7291782B2 (https=)
KR (1) KR102711257B1 (https=)
CN (1) CN112839928B (https=)
AU (1) AU2019350525B2 (https=)
CA (1) CA3112993A1 (https=)
DK (1) DK3856721T3 (https=)
ES (1) ES2943289T3 (https=)
GB (1) GB201815695D0 (https=)
IL (1) IL281636B2 (https=)
WO (1) WO2020065323A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009973A1 (en) * 2003-06-26 2005-02-03 Novartis Ag 5-membered heterocycle-based p38 kinase inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1809386A1 (de) 1968-11-16 1970-06-11 Bayer Ag Verfahren zur Herstellung von 1,5-disubstituierten 4-Cyanopyrazolen
US4686221A (en) * 1985-10-01 1987-08-11 Kanebo, Ltd. Quinolinecarboxylic acid compounds and antimicrobial agent containing the same
US6005109A (en) * 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
US6103900A (en) * 1992-12-17 2000-08-15 Pfizer Inc Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
FR2732967B1 (fr) 1995-04-11 1997-07-04 Sanofi Sa 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
HRP20000724A2 (en) * 1998-05-05 2001-06-30 Hoffmann La Roche Pyrazole derivatives as p-38 map kinase inhibitors
WO2005007632A1 (en) 2003-07-18 2005-01-27 Pharmacia Corporation Substituted pyridazinones as inhibitors of p38
US7485657B2 (en) 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
ATE510836T1 (de) 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
AU2008281594A1 (en) 2007-08-02 2009-02-05 Generics [Uk] Limited Novel process
WO2009088025A1 (ja) 2008-01-10 2009-07-16 Hokko Chemical Industry Co., Ltd. フェニルトリアゾリノン類の製造法
JP5602387B2 (ja) 2008-05-02 2014-10-08 キヤノン株式会社 インクジェット用インク、インクジェット記録方法、インクカートリッジ、記録ユニット、及びインクジェット記録装置
CN102964270B (zh) 2012-11-21 2015-01-07 合肥星宇化学有限责任公司 一种亚硫酸钠还原重氮盐合成肼的方法
WO2018059533A1 (zh) 2016-09-29 2018-04-05 南京明德新药研发股份有限公司 p38αMAPK激酶抑制剂及其制备方法和应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009973A1 (en) * 2003-06-26 2005-02-03 Novartis Ag 5-membered heterocycle-based p38 kinase inhibitors

Also Published As

Publication number Publication date
WO2020065323A1 (en) 2020-04-02
CN112839928B (zh) 2024-04-30
KR102711257B1 (ko) 2024-09-30
US20210395207A1 (en) 2021-12-23
JP2022502400A (ja) 2022-01-11
EP3856721A1 (en) 2021-08-04
DK3856721T3 (da) 2023-04-24
US11649213B2 (en) 2023-05-16
EP3856721B1 (en) 2023-03-29
IL281636B2 (en) 2024-08-01
AU2019350525A1 (en) 2021-04-15
CN112839928A (zh) 2021-05-25
IL281636B1 (en) 2024-04-01
JP7291782B2 (ja) 2023-06-15
KR20210069044A (ko) 2021-06-10
IL281636A (en) 2021-05-31
CA3112993A1 (en) 2020-04-02
GB201815695D0 (en) 2018-11-07
ES2943289T3 (es) 2023-06-12

Similar Documents

Publication Publication Date Title
AU2019350525B2 (en) Synthetic method for the preparation of a 3-[5-Amino-4-(3-Cyanobenzoyl)-Pyrazol compound
EP3856711B1 (en) Synthetic method for the preparation of an hydrazine compound
EP3856712B1 (en) Synthetic methodfor the preparation of an alkoxymethylene-benzoylacetonitrile
HK40049030B (en) Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound
HK40049030A (en) Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound
JP2717995B2 (ja) 1,2,3−トリアゾールの製法
KR900001081B1 (ko) 4-아실-5-피라졸릴 4-톨루엔 술포네이트 유도체의 제법
JP3097193B2 (ja) ピラゾール誘導体の製造方法
US6545163B1 (en) Process to prepare 1-aryl-2-(1-imidazolyl) alkyl ethers and thioethers
JP2000344742A (ja) 3−アミノ−1−フェニルピロリジン−2−オン誘導体の製造方法
JPH08277251A (ja) ジメチルホルムアミドジメチルアセタールの製造方法
JP2004277331A (ja) 3−アミノ−4−置換−5−ピラゾロン類の製造方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)